Gotham Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9M Sell
117,533
-13,244
-10% -$2.6M 0.06% 486
2026
Q1
$25.6M Buy
130,777
+51,382
+65% +$9.98M 0.08% 361
2025
Q4
$13.8M Buy
79,395
+24,701
+45% +$4.5M 0.05% 534
2025
Q3
$10.4M Buy
54,694
+24,881
+83% +$4.42M 0.05% 560
2025
Q2
$5.36M Buy
29,813
+20,529
+221% +$3.57M 0.03% 646
2025
Q1
$1.57M Buy
9,284
+7,943
+592% +$1.3M 0.01% 873
2024
Q4
$202K Sell
1,341
-525
-28% -$81.7K ﹤0.01% 1367
2024
Q3
$290K Sell
1,866
-4,879
-72% -$729K ﹤0.01% 1242
2024
Q2
$923K Sell
6,745
-11,414
-63% -$1.56M 0.01% 915
2024
Q1
$2.42M Buy
+18,159
New +$2.36M 0.04% 599
2023
Q2
Sell
-1,990
Closed -$282K 1326
2023
Q1
$282K Sell
1,990
-21,701
-92% -$3.1M 0.01% 1152
2022
Q4
$3.71M Buy
23,691
+3,073
+15% +$442K 0.1% 245
2022
Q3
$2.53M Sell
20,618
-8,304
-29% -$1.09M 0.08% 315
2022
Q2
$3.85M Sell
28,922
-3,623
-11% -$494K 0.12% 199
2022
Q1
$4.45M Buy
32,545
+8,782
+37% +$1.22M 0.14% 179
2021
Q4
$4.11M Sell
23,763
-9,983
-30% -$1.52M 0.13% 189
2021
Q3
$4.9M Buy
33,746
+15,807
+88% +$2.31M 0.2% 138
2021
Q2
$2.37M Sell
17,939
-8,138
-31% -$1.07M 0.1% 270
2021
Q1
$3.35M Sell
26,077
-28,059
-52% -$3.46M 0.15% 202
2020
Q4
$6.45M Buy
54,136
+43,183
+394% +$5.26M 0.21% 144
2020
Q3
$1.25M Sell
10,953
-1,547
-12% -$183K 0.04% 478
2020
Q2
$1.42M Sell
12,500
-82,470
-87% -$8.75M 0.04% 478
2020
Q1
$7.63M Buy
94,970
+1,121
+1% +$116K 0.21% 137
2019
Q4
$10M Buy
93,849
+4,659
+5% +$486K 0.18% 148
2019
Q3
$9.55M Buy
89,190
+14,753
+20% +$1.51M 0.17% 165
2019
Q2
$7.58M Sell
74,437
-47,633
-39% -$4.58M 0.12% 232
2019
Q1
$11M Buy
122,070
+252
+0.2% +$21.8K 0.16% 183
2018
Q4
$10.1M Buy
121,818
+63,675
+110% +$5.97M 0.16% 192
2018
Q3
$6.27M Buy
58,143
+55,519
+2,116% +$6.09M 0.09% 306
2018
Q2
$288K Sell
2,624
-162,206
-98% -$16.9M ﹤0.01% 785
2018
Q1
$16.5M Sell
164,830
-98,339
-37% -$10.1M 0.23% 144
2017
Q4
$25.9M Buy
263,169
+119,278
+83% +$11.3M 0.38% 65
2017
Q3
$13.5M Buy
143,891
+47,989
+50% +$5.09M 0.2% 163
2017
Q2
$10.7M Sell
95,902
-85,076
-47% -$9M 0.15% 215
2017
Q1
$17.8M Sell
180,978
-53,394
-23% -$5.09M 0.23% 143
2016
Q4
$21.5M Sell
234,372
-73,848
-24% -$6.36M 0.28% 117
2016
Q3
$26.1M Buy
308,220
+130,782
+74% +$11M 0.34% 86
2016
Q2
$14.4M Sell
177,438
-71,783
-29% -$5.47M 0.17% 194
2016
Q1
$17.8M Sell
249,221
-21,054
-8% -$1.41M 0.2% 168
2015
Q4
$19.2M Sell
270,275
-329,756
-55% -$22.2M 0.21% 159
2015
Q3
$36.9M Buy
600,031
+318,726
+113% +$22.3M 0.36% 84
2015
Q2
$20.4M Buy
281,305
+224,521
+395% +$16.6M 0.17% 200
2015
Q1
$4.36M Sell
56,784
-31,435
-36% -$2.25M 0.03% 442
2014
Q4
$5.92M Sell
88,219
-149,838
-63% -$9.46M 0.05% 401
2014
Q3
$14.4M Buy
238,057
+233,673
+5,330% +$14.4M 0.14% 227
2014
Q2
$257K Sell
4,384
-72,028
-94% -$4.22M ﹤0.01% 916
2014
Q1
$4.43M Sell
76,412
-202,776
-73% -$10.9M 0.07% 385
2013
Q4
$14.9M Buy
279,188
+235,126
+534% +$13.9M 0.36% 67
2013
Q3
$2.72M Buy
44,062
+12,868
+41% +$770K 0.09% 338
2013
Q2
$1.89M Buy
+31,194
New +$1.86M 0.08% 375

Other funds holding DGX

Gotham Asset Management's DGX Position: Q2 2026 in Review

Gotham Asset Management reduced its Quest Diagnostics (DGX) stake by 10% in Q2 2026, selling an estimated $2.6M and leaving 117,533 shares worth $24.9M. The position accounts for 0.06% of the portfolio, ranked #486.

Gotham Asset Management first reported a position in DGX in Q2 2013 and has held it in 50 quarters since. The position peaked at $36.9M in Q3 2015. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Gotham Asset Management held 117,533 shares of Quest Diagnostics worth $24.9M as of Q2 2026.
  • Gotham Asset Management sold 13,244 Quest Diagnostics shares in Q2 2026, an estimated $2.6M.
  • Quest Diagnostics made up 0.06% of Gotham Asset Management's portfolio in Q2 2026, its #486 holding.
  • Gotham Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 50 quarters since.
  • Gotham Asset Management's Quest Diagnostics position peaked at $36.9M in Q3 2015.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.